Company: PACB
Filing Date: 2025-03-17
Form Type: 10-K
Source: 0001299130-25-000061
Chunk: 176

Company: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Filing Date: 2025-03-17
Form: 10-K
Item: Item 1
Chunk 176
---
.8 million, and $7.8 million, respectively.As of December 31, 2024, $80.1 million of total unrecognized compensation expense related to stock options, restricted stock, and ESPP shares was expected to be recognized over a weighted-average period of 2.2 years.

NOTE 10.  NET LOSS PER SHAREThe following table presents the calculation of the basic and diluted net loss per share amounts presented on our consolidated statements of operations and comprehensive loss: Years Ended December 31,(in thousands, except per share amounts)202420232022Numerator:BasicBasic net loss$(309,851)$(306,735)$(314,248)DilutedBasic net loss$(309,851)$(306,735)$(314,248)Add: Interest charges applicable to convertible notes (2028 Notes)6,428 — — Less: Gain on debt restructuring (2029 Notes)(154,407)— — Diluted net loss$(457,830)$(306,735)$(314,248)Denominator:BasicWeighted-average shares used in computing basic net loss per share274,488 253,629 224,550 Basic net loss per share$(1.13)$(1.21)$(1.40)DilutedWeighted-average shares used in computing basic net loss per share274,488253,629224,550Add: Weighted average shares issuable upon conversion of convertible notes (2028 Notes)9,395——Add: Weighted average shares issuable upon conversion of convertible notes (2029 Notes)4,483——Weighted-average shares used in computing diluted net loss per share288,366253,629224,550Diluted net loss per share$(1.59)$(1.21)$(1.40)

Fiscal 2024 Form 10-K122

The following shares issuable upon conversion of the convertible senior notes and outstanding equity awards were excluded from the computation of diluted net loss per share for the periods presented because the effect of including such shares would have been antidilutive:Years Ended December 31,(in thousands)202420232022Shares issuable upon conversion of convertible senior notes20,51231,06320,690Equity awards34,13627,24627,291See Note 2. Business Acquisitions, for detailed information on contingently issuable shares that would be due upon achievement of a milestone. See Note 9. Stockholders’ Equity